Envision Pharma Group launches Medinfo™

PR icon

PRESS RELEASE

Mar 20, 2017

Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information

Glastonbury, USA, March 20, 2017 – Envision Pharma Group ("Envision"), a leading Medical Affairs-focused scientific communications and technology solutions provider, is pleased to announce the launch of Medinfo™ – a new purpose-built software solution for pharmaceutical medical information functions and associated professional contact center service providers.

Medinfo is a complete, globally scalable solution that transparently and compliantly manages the provision of medical information to healthcare professionals, patients, caregivers, and other enquirers. Medinfo is currently being implemented at several companies.

Medinfo is built on the iEnvision™ platform and is part of the integrated suite of iEnvision solutions, purpose-built to meet the needs of Medical Affairs and related functions. Medinfo can be fully integrated with other iEnvision solutions such as Datavision® (publications management), Library™ (scientific content asset management), and Clear® (system-managed clearance and approval processing), as well as other third-party and corporate applications including CRM, other CMS, pharmacovigilance, and product quality systems.

Validation, audit, and transparency reporting requirements are a key aspect, with standard Medinfo implementations being validated to Software Validation Process 21 CFR Part 11 Compliant GxP Standards. Further client-configured validation support is available.

Medinfo was developed in-house at Envision as a specific medical information solution under the guidance of a team of senior medical information specialists with over 35 years cumulative experience in hands-on, industry-based medical information roles. This was combined with Envision’s 15-year experience in providing medical request- and scientific communications-related technology solutions to create a robust, advanced, and purpose-specific solution for medical information needs.

Medinfo provides a next generation medical information solution comprising multichannel request intake using an integrated web portal, streamlined and simplified enquiry management processing with adverse event and product quality intake capabilities, system-suggested response generation support, and robust content creation and management facilities. Built-in analytical features including dashboards, metrics, and reporting enable insights to be captured, this in turn, can inform and improve response quality, as well as future data and evidence generation requirements. Medinfo quickly and efficiently helps get the right answer to the enquirer and enables actionable insights to improve future responses. In addition, the Operational Excellence Consulting arm of Envision is able to provide complementary standard response medical writing and implementation support services.

For further information, please contact: Kelli Walker (kelli.walker@EnvisionPharmaGroup.com) or Russell Traynor (Russell.Traynor@EnvisionPharmaGroup.com).

 

About Envision

Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies.

Envision is a leading provider of evidence communication services and industry-leading, technology solutions that have applicability across areas of Medical Affairs responsibility.

Under consistent leadership, Envision has grown steadily across its three core business areas in support of Medical Affairs:

(i) Evidence Communication—including strategic publication planning, data dissemination services, medical education, and Market Access communications;

(ii) Technology Solutions—design, development, implementation, and support of innovative and strategic management software, purpose-built for life-science clients, including: publication planning and management (Datavision®), clearance and approval (Clear®), activity request and evidence generation management (Visiontracker®), workflow management for Health Economics and Outcomes Research activities (Visiontracker HEOR™), workflow management for Early Access Program activities (Visiontracker EAP™), searchable repository for the appropriate sharing of scientific content (Library), and a next-generation solution for managing medical information enquiries (Medinfo™); and

(iii) Operational Excellence—policy, process, and compliance support and consultancy for Medical Affairs.

Envision has 12 offices: four in the United Kingdom – Horsham, Wilmslow, Marlow, and London; six in the United States – Philadelphia, PA, Southport, CT, Madison, NJ, Stirling, NJ, Glastonbury, CT, and Brooklyn, NY; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs 520 team members, including more than 200 highly qualified and experienced in-house medical writers and more than 100 technology solutions team members who provide software development and customer support. Envision provides services and technology solutions to more than 75 companies, including 19 of the top 20 pharmaceutical companies.

Envision Pharma Group logo